SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD

Review checklist: Higuchi Ichiyō (HR-NI029)
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
- 17judgment calls in the dossier
- 2protocol deviations
- 5orders and referrals without results in the record
- 0evidence items to check (retrospective or sensitive claims, unconfirmed diagnoses)
Review status
| Review | Status | Reviewer | Date | Notes |
|---|
| schema validation | not_started | | | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | | | Awaiting clinician review; check outpatient care for smear-negative, Xpert-positive disease in Japan, the six-month regimen chosen because her weight is below 40 kg, the weight-based doses, liver monitoring in a malnourished woman, and the recorded gap in month-one monitoring. |
| provenance review | not_started | | | National Diet Library portrait biography and calendar page, Kotobank encyclopedia entries (Nipponica and others), Nippon.com, the Ichiyō Memorial Museum page, the Bunkyō City biography, and the Bank of Japan banknote page logged. Danly's biography was not read. The form of her fatal tuberculosis differs between sources (pulmonary or miliary). |
| safe messaging review | not_started | | | No psychiatric claim is made; PHQ-9 at most 8 with item 9 scored 0, so no safety assessment is required. Her mother and sister appear only in documented history; the household contact investigation names no one and records no result. Her death is recorded in one sentence. |
Judgment calls (dossier editorial resolutions)
- Recent-death rule. She died in 1896, so the rule does not apply. Claims are limited to what the fetched sources state. No claim concerns mental health or substance use.
- Name (judgment call). Japanese order puts the family name first: Higuchi is the family name and Ichiyō a pen name; her given name was Natsu, also written Natsuko. The record uses the name she is known by, with identity.name_parts given “Ichiyō”, family “Higuchi” and family_first true, as other family-name-first records do; the notes call her Ms. Higuchi. The macron in Ichiyō is kept throughout. The aliases “Higuchi Natsu” and “Higuchi Natsuko” appear in no other record. The National Diet Library English page labels “Natsu” a pen name; the Japanese encyclopedias give なつ as her real name (本名), which the record follows.
- Birth date and calendar. Japan used a lunisolar calendar until the end of Meiji 5, when the 3rd day of the 12th month became January 1, 1873 (National Diet Library). Her birth, Meiji 5, 3rd month, 25th day, is given by Nipponica as May 2 in the new calendar, which the National Diet Library and Nippon.com also give; the record uses the Gregorian date and notes the original. Her death in 1896 is in the Gregorian calendar.
- Corrections to the brief. The “about fourteen months” of major work is Nippon.com’s phrase (“the miraculous 14 months”); Nipponica speaks of “the miraculous year” ending in January 1896. Both are recorded in CLM-0008. The cause of death is tuberculosis in every source, but the National Diet Library gives lung tuberculosis and Nipponica miliary tuberculosis; CLM-0011 records both, and the modern pulmonary diagnosis is linked to the documented disease without choosing between them. The shop was in Shitaya Ryūsenji-chō beside the Yoshiwara from July 1893 to April 1894, about ten months.
- Index age and dates. The index visit on April 14, 2026 maps to April 14, 1896, when she was 23 and living in Hongō Maruyama-Fukuyama-chō, after her health began to decline early in 1896 and before her death on November 23, 1896. The synthetic date of birth is May 2, 2002 (shift 130 years). All visits, through October 20, 2026 (October 20, 1896), fall within her lifetime; she turns 24 between the third and fourth visits. The modern visits are a teaching episode, not a claim about her real care or condition on those dates.
- Presenting problem. Seven weeks of cough, fevers, night sweats and weight loss at intake is its own problem (R05.3, chronic cough), resolved at the results visit three days later when pulmonary tuberculosis (A15.0) is recorded. The intake documents show only what was known then. Malnutrition (E44.0) and low income (Z59.6) are recorded at intake.
- Smear-negative, outpatient care (judgment call). The record makes her smear-negative with a positive Xpert MTB/RIF Ultra result (“low”) and no cavity. In Japan, patients at risk of infecting others are admitted to a tuberculosis ward on the public health center’s recommendation; smear-negative patients are usually treated as outpatients with public funding of 95 percent of costs (Article 37-2). The record therefore keeps her at home with precautions and ends them after two weeks of treatment with clinical improvement, with the public health center’s agreement. A reviewer should confirm this reading of Japanese practice.
- Regimen choice (judgment call). The brief allowed either regimen. At 38.4 to 38.5 kg she is below the 40 kg the CDC 2022 interim guidance requires for the four-month rifapentine-moxifloxacin regimen, so the standard six-month regimen is used. Whether rifapentine is available in Japan was not confirmed from a fetched source and did not decide the choice. Doses are weight-based: isoniazid 200 mg, rifampin 450 mg, pyrazinamide 1000 mg and ethambutol 600 mg, with pyridoxine 50 mg. Ethambutol is stopped after five weeks when the isolate proves susceptible; the continuation phase is four months because there was no cavity.
- Focused visits. The four chronic-care follow-ups (results visit with the consultation, two weeks, the end of the intensive phase at eight weeks, and the end of treatment) are documented as focused visits on the ATS/CDC/IDSA 2016 guideline and its 2025 update, the WHO 2022 guideline, the ATS hepatotoxicity statement, the CDC contact-investigation guideline, and the Japanese notification and funding rules. Two deviations are recorded at the eight-week visit instead of invented results: the liver tests and the vision check due about four weeks into treatment were not done, because no visit was booked and the phone call that stopped ethambutol did not include them; no harm judging by normal liver tests and unchanged acuity at eight weeks; tests due between visits are now booked as laboratory visits, and future ethambutol courses with monthly vision checks. Liver tests in the continuation phase are for symptoms only, because the intensive-phase tests stayed normal and albumin recovered; this follows the ATS approach for patients without ongoing risk factors and is a judgment call.
- Consultation. The infectious diseases referral and the consultation by Hiroshi Abernathy-Okoye, MD (a fictional consultant), on the day of the results visit, are S. The consultant answers the six referral questions in line with what the record shows afterwards: Xpert confirms tuberculosis despite negative smears; the six-month regimen because she is under 40 kg; outpatient care with precautions for two weeks; liver tests at two weeks and monthly in the intensive phase and vision checks while on ethambutol (the month-one checks were missed, as recorded); ethambutol stopped on susceptibility and a four-month continuation phase; and a contact investigation by the public health center.
- Real people. Her mother and younger sister, her father, Nakajima Utako and Nakarai Tōsui appear only in documented history claims. The modern social history describes a household of three adults without naming anyone, and the contact investigation records no statement, decision or result for any household member: their results are said to belong to their own records. No relative is the health care agent; the agent is unnamed. The father’s death is recorded in family history as “cause not recorded in the cited source”.
- Equity and culturally appropriate care. The record treats poverty as a clinical problem: public funding is applied for on the day of diagnosis, a medical social worker arranges instalments, the dietitian’s plan uses affordable foods she already eats, and the writing plan protects her income. The fear of stigma among neighbors and editors is recorded as her concern, and the precautions are explained so that they end as soon as it is safe.
- Sick visit. Acute uncomplicated cystitis in the continuation phase, chosen because it teaches two tuberculosis lessons: rifampin colors urine and can make dipstick color pads unreliable, so microscopy and culture are used, and fluoroquinolones are avoided during tuberculosis treatment. Nitrofurantoin does not interact with isoniazid or rifampin. It implies no real diagnosis.
- Preventive visit. A periodic adult preventive visit at 24 (CPT 99395 with 99497 in plain text). Judgment calls: first cervical cytology at 24; chlamydia and gonorrhea screening not indicated because she is not sexually active; contraception counseling about the rifampin interaction; Tdap, hepatitis B (two doses) and catch-up HPV vaccination (doses 1 and 2 in the record, dose 3 due afterwards); influenza vaccine at the end-of-treatment visit; advance care planning limited to her own general preferences, with an unnamed agent.
- Setting. The modern frame is a clinic in Tokyo within Japan’s public health system. The record keeps the project’s conventions (the fictional facility name, a synthetic SSN, CPT codes in plain text, USPSTF and CDC preventive guidance) and adds the Japanese notification and funding rules.
- Synthetic content. All visits, laboratory values, vital signs, X-ray findings, bacteriology (smears, Xpert, culture, susceptibility), survey scores, medicines and doses, the cystitis, her height (148 cm) and weights, her diet, the household arrangements, the public funding and instalments, and the health care agent are synthetic. Qualitative results (smears, Xpert, cultures, susceptibility, HIV, hepatitis and pregnancy tests, urine microscopy and culture, cervical cytology) appear only in the note text.
- Sources not used. Robert Lyons Danly’s In the Shade of Spring Leaves (Yale University Press, 1981) was found only as catalogue records and was not read; no claim rests on it. Britannica returned an access error. A personal website’s statement that her symptoms began in the spring of 1896 with high fevers in July, and details of the physicians who examined her in 1896, were not confirmed from a reliable fetched source and are left out.
Protocol deviations
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|
2026-06-12 Progress note 04 (C-CDA) | Monthly liver tests in the intensive phase (month one) | Monthly in the intensive phase because of low weight and albumin | Missed: the liver tests due about four weeks into treatment were not drawn, because no visit was booked and the phone call that stopped ethambutol did not include a blood test. No harm judging by today's normal results and the absence of symptoms at every observed dose. Corrective action: blood tests due between visits are now booked as laboratory visits with a reminder to the observing nurse |
2026-06-12 Progress note 04 (C-CDA) | Visual acuity and color vision | Baseline and monthly while on ethambutol | Missed: the monthly vision check due about four weeks into treatment, while she was still taking ethambutol, was not done for the same reason. No harm: acuity 85 letters in each eye and normal color vision today, three weeks after ethambutol was stopped. Corrective action: any future ethambutol course is booked with monthly vision checks |
Orders and referrals without results in the record
| Visit | Type | Item | Status | Detail |
|---|
2026-04-17 Progress note 02 (C-CDA) | Laboratory | Drug susceptibility testing of the first isolate | Ordered | Phenotypic susceptibility to first-line drugs to be set up on the first positive culture |
2026-04-17 Progress note 02 (C-CDA) | Referral | Contact investigation (household and close contacts) | Referred | The public health center will assess her household and close contacts; their results belong to their own records |
2026-05-01 Progress note 03 (C-CDA) | Laboratory | Drug susceptibility testing of the first isolate | Ordered | Set up on the isolate; result expected in about three weeks |
2026-05-01 Progress note 03 (C-CDA) | Referral | Contact investigation (household and close contacts) | Referred | Under way with the public health center; results not part of her record |
2026-06-12 Progress note 04 (C-CDA) | Referral | Contact investigation (household and close contacts) | Referred | Continuing with the public health center; results not part of her record |
Evidence to check
Retrospective claims (R)
None.
Sensitive claims
None.
Diagnoses not confirmed
None.
Notes to read
Every note in the record, with its type. All clinical content is synthetic.
Abnormal results
| Date | Result | Value | Flag |
|---|
| 2026-04-14 | Hemoglobin | 11.4 g/dL (low) | Low |
| 2026-04-14 | Platelets | 452 10*3/uL (high) | High |
| 2026-04-14 | Albumin | 3.3 g/dL (low) | Low |